3928 POINT EDEN WAY, HAYWARD, CA
Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update
Annual Report to Security Holders
Other Events
COO Resignation - Jennifer Jarrett Steps Down from Arcus Biosciences
Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
Material disclosure
Arcus Biosciences Announces Public Offering of 13.7 Million Shares
Q1
FY 2025
Q3
Q2
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Amended Notice of Proposed Sale of Securities
Submission Upload
Correspondence